Susquehanna International Group, LLP Titan Pharmaceuticals Inc Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$0.26 - $0.48 $11,062 - $20,423
-42,549 Reduced 68.47%
19,596 $8,000
Q3 2023

Nov 14, 2023
BUY
$0.45 - $0.66 $27,965 - $41,015
62,145 New
62,145 $29,000
Q4 2021

Feb 14, 2022
BUY
$1.02 - $1.93 $39,708 - $75,134
38,930 New
38,930 $40,000

Others Institutions Holding TTNP

# of Institutions
1
Shares Held
23
Call Options Held
0
Put Options Held
0
View Full List

About TITAN PHARMACEUTICALS INC

TTNP Quotes by TradingView
  • Ticker TTNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,629,200
  • Market Cap $58.5M
  • Description
  • Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in clinically stable patients in Canada and the Euro...
More about TTNP
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email